Aclaris Therapeutics reports excellent results from A-101 Phase 2 trial for removing SK lesions Aclaris Therapeutics, Inc. Today announced positive results from a Phase 2 scientific trial of the Firm's lead drug, A-101. In the trial, A-101 demonstrated clinically and statistically significant improvements in clearing seborrheic keratoses , one of the most common types of pores and skin tumors. While benign, many patients elect to have SK treated either as the lesions have grown to be are or irritated cosmetically concerning. The double-blind, placebo-controlled Phase 2 medical trial was designed to evaluate the security, tolerability, and efficacy of A-101 in eliminating SK lesions.‘I think AMC is doing an awesome job because we should be protecting our people if they arrive and they should be feeling safe,’ said Regina Law, oblivious to the actual fact that if someone truly wants to perform moviegoers harm, they will not wait to end up being ‘reported’ and won’t pay much focus on ‘No Firearms Allowed’ rules. ‘I believe it’s good to make people aware because some people just move in the theater, sit down plus they are not aware of what’s happening around them because they’re just excited,’ added Mchugh, who doesn’t see the irony in paying therefore much focus on ‘suspicious people’ that she wouldn’t have much of an opportunity to actually enjoy the movie. Actually, honestly, most people go into a theater and just ‘sit back’ to watch a movie just because a) that’s why they proceeded to go to the movies to begin with; and b) movie home shootings are much less common than Vice President Joe Biden sticking his huge foot in his big mouth.